Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobazam adjunctive therapy in drug-resistant epilepsy with comorbid anxiety
ChiCTR2400095079Phase 4Recruiting
- Sponsor
- Department of Neurology, Affiliated Hospital of Zunyi Medical University
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clobazam in epilepsy and generalized anxiety disorder (GAD), sponsored by Department of Neurology, Affiliated Hospital of Zunyi Medical University. Primary endpoints: Frequency of seizures at month 6 and Degree of improvement in anxiety at month 6. Started Dec 2024; status: recruiting.
02
Drugs
clobazam
03
Conditions
epilepsygeneralized anxiety disorder (GAD)
Beyond the preview
Go deeper on ChiCTR2400095079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400095079.